{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:27:26Z","timestamp":1786973246479,"version":"build-2736575974"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD091350"],"award-info":[{"award-number":["HD091350"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Combined oral contraceptives (OCPs) and metformin are commonly used in patients with polycystic ovary syndrome (PCOS), who are at elevated risk of dyslipidemia and cardiovascular disease (CVD), but their effects on advanced lipid phenotyping remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the impact of OCPs and metformin on (1) lipoproteins, (2) apolipoproteins, and (3) cholesterol efflux capacity (CEC, marker of HDL function).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Secondary analysis of the COMET-PCOS randomized clinical trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Two tertiary care reproductive endocrinology clinics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients or Other Participants<\/jats:title>\n                    <jats:p>Patients with hyperandrogenic PCOS and elevated BMI with paired serum samples for lipoprotein\/apolipoprotein analysis (n = 180) and cholesterol efflux capacity (n = 129).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention(s)<\/jats:title>\n                    <jats:p>24 weeks of metformin, OCP, or OCP + metformin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measure(s)<\/jats:title>\n                    <jats:p>Change in HDL particles (HDL-P), low-density lipoprotein particles (LDL-P), triglyceride-rich lipoprotein particles (TRL-P); apolipoproteins A-I, B, and C-III; and CEC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HDL-P concentration increased in the OCP and OCP + metformin arms, while atherogenic small LDL-P increased slightly. Metformin had a largely neutral effect on advanced lipid phenotyping. Cholesterol efflux capacity increased in the OCP arm, though this was attenuated when adjusting for change in ApoA-I (adjusted ratio of geometric means 1.08, 95% CI 0.99-1.17), which increased in all arms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with PCOS and high metabolic risk, OCP use resulted in improved HDL-C function and a mixed effect on lipoproteins and apolipoproteins, with no clear benefit from metformin. These findings do not support or refute the cardiovascular risk-benefit of OCP use in PCOS and highlight the need for studies evaluating long-term clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag149","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T11:10:27Z","timestamp":1786101027000},"page":"302-311","source":"Crossref","is-referenced-by-count":0,"title":["Impact of oral contraceptives and metformin on advanced lipid phenotyping in polycystic ovary syndrome"],"prefix":"10.1093","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4319-4429","authenticated-orcid":false,"given":"Iris T","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E","family":"Soffer","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T","family":"Remaley","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute , Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P","family":"Playford","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute , Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal N","family":"Mehta","sequence":"additional","affiliation":[{"name":"George Washington University School of Medicine and Health Sciences , Washington, District of Columbia 20037 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Coutifaris","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S","family":"Legro","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, M.S. Hershey Medical Center , Hershey, PA 17033 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Dokras","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"issue":"10","key":"2026081708564053600_lvag149-B1","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5 Pt 2","key":"2026081708564053600_lvag149-B2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.fertnstert.2025.08.033","article-title":"Association of polycystic ovary syndrome with atherosclerotic cardiovascular disease events","volume":"124","author":"Lee","year":"2025","journal-title":"Fertil Steril"},{"issue":"3","key":"2026081708564053600_lvag149-B3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"issue":"10","key":"2026081708564053600_lvag149-B4","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1530\/EC-20-0423","article-title":"Effects of oral contraceptives on metabolic parameters in adult premenopausal women: a meta-analysis","volume":"9","author":"Silva-Bermudez","year":"2020","journal-title":"Endocr Connect"},{"key":"2026081708564053600_lvag149-B5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1127104","article-title":"Investigating cardiovascular risk in premenopausal women on oral contraceptives: systematic review with meta-analysis","volume":"10","author":"Fabunmi","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2026081708564053600_lvag149-B6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/humrep\/deq301","article-title":"The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies","volume":"26","author":"Halperin","year":"2011","journal-title":"Hum Reprod"},{"key":"2026081708564053600_lvag149-B7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.metabol.2017.05.001","article-title":"Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: a meta-analysis comparing products containing cyproterone acetate with third generation progestins","volume":"73","author":"Amiri","year":"2017","journal-title":"Metabolism"},{"issue":"2","key":"2026081708564053600_lvag149-B8","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1093\/ejendo\/lvad098","article-title":"The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"189","author":"Melin","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026081708564053600_lvag149-B9","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/cen.13310","article-title":"Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome","volume":"86","author":"Dokras","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026081708564053600_lvag149-B10","doi-asserted-by":"publisher","first-page":"774418","DOI":"10.3389\/fcvm.2021.774418","article-title":"Cholesterol efflux capacity and its association with adverse cardiovascular events: a systematic review and meta-analysis","volume":"8","author":"Lee","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"2026081708564053600_lvag149-B11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jacl.2011.02.001","article-title":"Clinical implications of discordance between low-density lipoprotein cholesterol and particle number","volume":"5","author":"Otvos","year":"2011","journal-title":"J Clin Lipidol"},{"issue":"5","key":"2026081708564053600_lvag149-B12","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1016\/j.jacl.2024.08.013","article-title":"Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: an expert clinical consensus from the National Lipid Association","volume":"18","author":"Soffer","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"11","key":"2026081708564053600_lvag149-B13","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1210\/jc.2015-2566","article-title":"Lipoprotein particles in adolescents and young women with PCOS provide insights into their cardiovascular risk","volume":"100","author":"Gourgari","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026081708564053600_lvag149-B14","doi-asserted-by":"publisher","first-page":"E841","DOI":"10.1210\/jc.2013-3918","article-title":"Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS","volume":"99","author":"Roe","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026081708564053600_lvag149-B15","doi-asserted-by":"publisher","first-page":"e1004662","DOI":"10.1371\/journal.pmed.1004662","article-title":"Impact of combined hormonal contraceptives and metformin on metabolic syndrome in women with hyperandrogenic polycystic ovary syndrome and obesity: the COMET-PCOS randomized clinical trial","volume":"22","author":"Dokras","year":"2025","journal-title":"PLoS Med"},{"issue":"12","key":"2026081708564053600_lvag149-B16","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2337\/diacare.25.12.2165","article-title":"The diabetes prevention program (DPP): description of lifestyle intervention","volume":"25","author":"Diabetes Prevention Program (DPP) Research Group","year":"2002","journal-title":"Diabetes Care"},{"issue":"1","key":"2026081708564053600_lvag149-B17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2012.06.068","article-title":"Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis","volume":"224","author":"Mehta","year":"2012","journal-title":"Atherosclerosis"},{"issue":"3","key":"2026081708564053600_lvag149-B18","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2025.030506","article-title":"The association between cholesterol efflux capacity and apolipoprotein A1: systematic review and meta-analysis","volume":"35","author":"\u010cerniauskas","year":"2025","journal-title":"Biochem Med (Zagreb)"},{"issue":"6","key":"2026081708564053600_lvag149-B19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1210\/jcem-54-6-1113","article-title":"High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel","volume":"54","author":"Tikkanen","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"issue":"20","key":"2026081708564053600_lvag149-B20","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism","volume":"323","author":"Godsland","year":"1990","journal-title":"N Engl J Med"},{"issue":"8","key":"2026081708564053600_lvag149-B21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/s1047-2797(97)00119-1","article-title":"Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study","volume":"7","author":"Greenlund","year":"1997","journal-title":"Ann Epidemiol"},{"issue":"5","key":"2026081708564053600_lvag149-B22","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/0002-9378(93)90279-r","article-title":"A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins","volume":"169","author":"Crook","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"26","key":"2026081708564053600_lvag149-B23","doi-asserted-by":"publisher","first-page":"23742","DOI":"10.1074\/jbc.M102348200","article-title":"ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein","volume":"276","author":"Wang","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"2026081708564053600_lvag149-B24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12013-022-01081-5","article-title":"Different pathways of cellular cholesterol efflux","volume":"80","author":"Dergunov","year":"2022","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"2026081708564053600_lvag149-B25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/ATVBAHA.113.302401","article-title":"New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease","volume":"34","author":"Tsai","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2026081708564053600_lvag149-B26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0010-7824(93)90086-M","article-title":"A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids","volume":"39","author":"Kakis","year":"1994","journal-title":"Int J Fertil Menopausal Stud"},{"issue":"14","key":"2026081708564053600_lvag149-B27","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.jacc.2024.07.034","article-title":"Quantifying triglyceride-rich lipoprotein atherogenicity, associations with inflammation, and implications for risk assessment using non-HDL cholesterol","volume":"84","author":"Bj\u00f6rnson","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"2026081708564053600_lvag149-B28","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.jacc.2023.02.034","article-title":"Clinical trial design for triglyceride-rich lipoprotein-lowering therapies","volume":"81","author":"Malick","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2026081708564053600_lvag149-B29","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1172\/JCI113667","article-title":"Relationship between lipoprotein lipase activity and plasma sex steroid level in obese women","volume":"82","author":"Iverius","year":"1988","journal-title":"J Clin Invest"},{"issue":"2","key":"2026081708564053600_lvag149-B30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.atherosclerosis.2009.03.003","article-title":"Metformin restores impaired HDL-mediated cholesterol efflux due to glycation","volume":"206","author":"Matsuki","year":"2009","journal-title":"Atherosclerosis"},{"issue":"10","key":"2026081708564053600_lvag149-B31","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1210\/jc.2013-1452","article-title":"Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the diabetes prevention program","volume":"98","author":"Goldberg","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag149\/70632524\/lvag149.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/2\/302\/70632524\/lvag149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/2\/302\/70632524\/lvag149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:56:50Z","timestamp":1786971410000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/195\/2\/302\/8760851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag149","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8]]}}}